Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Merit Medical Systems, Inc.    MMSI

MERIT MEDICAL SYSTEMS, INC.

(MMSI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

The Law Offices of Frank R. Cruz : Announces the Filing of a Securities Class Action on Behalf of Merit Medical Systems, Inc. Investors (MMSI)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/16/2020 | 12:01pm EST

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors that acquired Merit Medical Systems, Inc. (“Merit” or the “Company”) (NASDAQ: MMSI) common stock between February 26, 2019 and October 30, 2019, inclusive (the “Class Period”). Merit investors have until February 3, 2020 to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On July 25, 2019, post-market, the Company announced disappointing financial results for second quarter 2019, reporting net income of $6.9 million, or $0.12 per share, compared to $10.9 million, or $0.21 per share for the same period in the prior year. Merit’s Chief Executive Officer cited “a number of factors affecting revenues and gross margins during the second quarter,” including “foreign exchange [and] slower than anticipated conversion and uptake of acquired products.”

On this news, the Company’s stock price fell $13.84, or over 25%, to close at $41.00 on July 26, 2019, thereby injuring investors.

On October 30, 2019, the Company announced its third quarter 2019 financial results, lowered revenue guidance for fiscal 2019, and eliminated previously issued guidance for fiscal 2020.

On this news, the Company’s stock price fell $8.45, or 29%, to close at $20.66 per share on October 31, 2019, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (2) that sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during fiscal 2019; and (3) that in light of the foregoing, the Company's reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Merit securities during the Class Period, you may move the Court no later than February 3, 2020 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you purchased Merit securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


© Business Wire 2020
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERIT MEDICAL SYSTEMS, INC
10:48aMERIT MEDICAL SYSTEMS INC : Other Events, Financial Statements and Exhibits (for..
AQ
01/27Merit Medical Issues Statement Regarding Director Nominations From Starboard
GL
01/27MERIT MEDICAL : Additional proxy soliciting materials filed by non-management
PU
01/23MERIT MEDICAL : Annual filing director officer or owner of more than ten percent..
PU
01/23IMPORTANT MERIT MEDICAL SYSTEMS, INC : Wolf Haldenstein Adler Freeman & Herz LLP..
PR
01/21MERIT MEDICAL : Report of unscheduled material events or corporate event
PU
01/16THE LAW OFFICES OF FRANK R. CRUZ : Announces the Filing of a Securities Class Ac..
BU
01/13THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation on Behalf of Merit Me..
BU
01/09Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merit Medica..
PR
2019MMSI LOSS NOTICE : TOP RANKED ROSEN LAW FIRM Reminds Merit Medical Systems, Inc...
BU
More news
Financials (USD)
Sales 2019 989 M
EBIT 2019 114 M
Net income 2019 15,2 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 119x
P/E ratio 2020 56,6x
Capi. / Sales2019 2,09x
Capi. / Sales2020 1,97x
Capitalization 2 066 M
Chart MERIT MEDICAL SYSTEMS, INC.
Duration : Period :
Merit Medical Systems, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERIT MEDICAL SYSTEMS, INC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 36,63  $
Last Close Price 37,42  $
Spread / Highest target 47,0%
Spread / Average Target -2,12%
Spread / Lowest Target -30,5%
EPS Revisions
Managers
NameTitle
Fred P. Lampropoulos Chairman, President & Chief Executive Officer
Ronald A. Frost Chief Operating Officer
Raul Parra Chief Financial Officer & Treasurer
Joseph Pierce Chief Information Officer
Jason Treft Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
MERIT MEDICAL SYSTEMS, INC.19.86%1 991
HENRY SCHEIN, INC.6.10%10 388
CANTEL MEDICAL CORP.-4.81%2 893
SHIP HEALTHCARE HOLDINGS, INC.0.40%2 197
PATTERSON COMPANIES14.01%2 190
AS ONE CORPORATION1.50%1 741